Randomized controlled trials have established that mammography reduces breast cancer mortality. However, mammography is less effective in women with dense breasts.
Expert commentary on Practice Bulletin #164: Diagnosis and Management of Benign Breast Disorders.
A new report from The American Cancer Society shows that in every US state, breast cancer incidence rates are higher in non-Hispanic white (NHW) women than in non-Hispanic black (NHB) women, but rates of death from the disease, however, are higher in NHB women than in NHW women. Also: Is second-stage labor longer with epidural analgesia? Plus, a study finds that ovarian reserve biomarkers are not associated with fertility.
One study looks at whether or not women with histories of breast or ovarian cancer are receiving necessary genetic testing. Plus: Can in-office hysteroscopy reliably evaluate uterine pathology? Also, researchers say mammographic density changes should be monitored in patients undergoing hormone therapy as a possible indicator of breast cancer.
Is this the next wave of medical professional liability lawsuits?
A study looks at who is being tested for BRCA mutations as testing becomes more common. Also, a look at the impact of Zika virus on birth defects using benchmark data. Plus: How is the United States doing with infant mortality?
We read with interest the article “Breast density laws: Are you in compliance?” [December 2016 Contemporary OB/GYN]. We appreciated the perspective of our gynecologist colleagues. We would like to help clarify and give context to some of the information in the article.
A study looks at the effectiveness of a dendritic cell vaccine in early-stage HER2-positive breast cancer. Plus: A look at whether fish oil consumed during pregnancy reduces the risk of asthma in offspring.
Meant to alert women that breast cancer may be more difficult to detect, the laws confuse physicians and patients alike.